Data from genetic and comorbidity studies may provide additional insight into understanding stuttering and developing better treatment strategies, according to a presentation by Shelly Jo Kraft, PhD, MS, at the STARS (Stuttering Treatment and Research Society) Inaugural Education and Research Conference.
“Stuttering is a unique condition in that it is labeled in the ICD [International Classification of Diseases], its labeled in DSM, yet we have no effective treatments for this condition that has existed since really the dawn of human history,” Gerald A. Maguire, MD, told Psychiatric Times in an exclusive interview at the STARS Inaugural Education and Research Conference.
At a recent conference on stuttering, Shahriar SheikhBahaei, PhD, assistant professor of neurobiology and behavior at SUNY Stony Brook University, discussed new insights into the neurobiology of speech and the mechanisms that may contribute to stuttering.
At the recent STARS Stuttering Treatment and Research Conference, experts emphasized the critical role of interdisciplinary care in treating stuttering, highlighting the need for collaboration across pediatrics, psychiatry, psychology, and speech-language pathology.
The newly founded nonprofit Stuttering Treatment and Research Society (STARS) announced groundbreaking news that it is the first organization to focus on uncovering the root cause of stuttering through advanced neuroscience-based research and comprehensive treatment methods.